AIDS/HIV (Transmission)

Prenatal Zidovudine Use Reduces Numbers of HIV Infected Babies

Published in Women's Health Weekly, October 2nd, 1995

Even though the numbers are leveling off, if pregnant women with HIV can be identified and targeted, the prophylactic use of the drug zidovudine (AZT) could drastically reduce the chances of the baby being born with HIV, researchers report.

Following a big surge in the number of babies born with HIV in the 1980s, the numbers peaked in 1991 and they are now stabilizing, according to an article in the September 20, 1995, issue of the Journal of the American Medical Association.

Susan F. Davis, M.D., from the National Centers for Infectious Disease, U.S. Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, and colleagues estimate that...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1995-10-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry